In lung adenocarcinoma, increased ROS levels have been reported to correlate negatively with cytotoxic T-cell infiltration, DC maturation, and antigen-presenting capacity, and to predict resistance to PD-1/PD-L1 inhibitors [132]. This evidence concerns the gene PDCD1 and lung adenocarcinoma.